Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 3;17(1):29.
doi: 10.1007/s11657-021-01041-1.

Exploring the treatment gap among patients with osteoporosis-related fractures in France

Patrice Fardellone  1 , Lianne Barnieh  2 , Nadia Quignot  2 , Gaelle Gusto  2 , Artak Khachatryan  3 , Doreen A Kahangire  4 , Gavin Worth  5 , James O'Kelly  4 , Gaelle Desamericq  6
Affiliations

Exploring the treatment gap among patients with osteoporosis-related fractures in France

Patrice Fardellone et al. Arch Osteoporos. .

Abstract

The use of anti-osteoporosis treatment following a diagnosis of osteoporosis with fracture or a relevant fragility fracture remains low in France. Initiating an anti-resorptive may reduce the incidence of a subsequent fracture by 60%.

Purpose: To describe real-world osteoporosis treatment patterns in individuals with a fragility fracture in France and to explore the impact of initiating treatment on the risk of subsequent fracture.

Methods: A retrospective cohort study, using the national French Health Insurance claims database. Males and females 50 years and over, with a hospital discharge diagnosis of osteoporosis with fracture or a relevant fragility fracture between 2011 and 2014, were included and followed until death or the end of 2016, whichever came first. The primary outcome was the proportion of patients receiving anti-osteoporosis treatments prior to and post-index fracture. Change in fracture rates before and after treatment initiation was assessed in an exploratory analysis.

Results: A total of 574,133 patients (138,567 males, 435,566 females) had a qualifying index fracture. The proportion of patients receiving any anti-osteoporosis treatment increased pre-index fracture to post-index fracture from 2.2 to 5.6% among males, and from 11.8 to 18.2% among females. Oral bisphosphonates were the most prescribed anti-osteoporosis treatment for both males and females among post-index fractures (60.6% and 68.8% of patients initiating treatment). Following initiation of anti-resorptives, the incidence of subsequent fracture was reduced by 60% (rate ratio (RR): 0.40, 95% confidence interval [CI]: 0.34-0.45).

Conclusion: Anti-osteoporosis treatment following an index fracture in France remains low. Improved identification and pharmacologic management of patients at risk of fragility fractures are necessary to reduce the risk of subsequent fractures.

Keywords: Anti-resorptives; Fracture risk reduction; Osteoporosis; Pharmacologic management.

PubMed Disclaimer

References

    1. Caliri A, De Filippis L, Bagnato GL, Bagnato GF (2007) Osteoporotic fractures: mortality and quality of life. Panminerva Med 49(1):21–27 - PubMed
    1. Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15(1):59 - DOI - PubMed - PMC
    1. Briot K, Roux C, Thomas T, Blain H, Buchon D, Chapurlat R et al (2018) 2018 update of French recommendations on the management of postmenopausal osteoporosis. Joint Bone Spine 85(5):519–530 - DOI - PubMed
    1. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK et al (2018) Osteoporosis: a review of treatment options. P & T : A Peer-Rev J Form Manag 43(2):92–104
    1. Bannay A, Chaignot C, Blotière PO, Basson M, Weill A, Ricordeau P et al (2016) The best use of the Charlson comorbidity index with electronic health care database to predict mortality. Med Care 54(2):188–194 - DOI - PubMed

Publication types

Substances

LinkOut - more resources